ELONOX® and ELONOX® HP are a biosimilar option to LOVENOX® and LOVENOX® HP1,2.
Covered in all provinces, including Ontario
(criteria may apply)*
Starting patients on ELONOX® (enoxaparin)?
Login to learn more!
*Special Authorization required in BC, SK, MB, and NFLD.
For customer service or to order:


ELONOX® is backed by the KabiCare Patient Support Program
Simple enrolment
Reimbursement support
Financial assistance
Injection training materials
Dedicated call centre
First-dose sampling program**
** Available at select partner sites only. First dose supply varies by clinic.
References:
- 1. ELONOX® and ELONOX® HP Product Monograph. Fresenius Kabi Canada Ltd. October 26, 2022.
- 2. LOVENOX® Product Monograph. Sanofi Aventis Canada, Inc. September 7, 2021.